Topical mitomycin in endoscopic-assisted probing for the treatment of congenital nasolacrimal duct obstruction in older children.
Alicia F GalindoRajiv KhandekarPatrícia Mitiko Santello AkaishiAntonio Augusto Velasco CruzAlberto Galvez-RuizAngela DolmetschSilvana Artioli SchelliniPublished in: Arquivos brasileiros de oftalmologia (2020)
Although mitomycin C has no adverse effects when applied to the opening of the nasolacrimal duct, its use after lacrimal probing for the treatment of congenital nasolacrimal duct obstruction does not improve the chance of success.